Calcium entry and the contraction of vascular smooth muscle.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000378:metabolism* / Q000502:physiology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D003331:Coronary Vessels / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors; D015237:Dinoprost; D004285:Dogs; D004789:Enzyme Activation; D009131:Muscle, Smooth, Vascular / Q000378:metabolism* / Q000502:physiology; D009219:Myosin-Light-Chain Kinase; D009638:Norepinephrine / Q000494:pharmacology; D011460:Prostaglandins F / Q000502:physiology; D011494:Protein Kinases / Q000378:metabolism; D012501:Saphenous Vein / Q000378:metabolism; D014661:Vasoconstriction / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D016861:Cyclooxygenase Inhibitors; D011460:Prostaglandins F; D015237:Dinoprost; D011494:Protein Kinases; D009219:Myosin-Light-Chain Kinase; D002118:Calcium; D009638:Norepinephrine